Estrogen Receptor Ligands and Regulation of Gene Expression
Sheng, Shubin
This item is only available for download by members of the University of Illinois community. Students, faculty, and staff at the U of I may log in with your NetID and password to view the item. If you are trying to access an Illinois-restricted dissertation or thesis, you can request a copy through your library's Inter-Library Loan office or purchase a copy directly from ProQuest.
Permalink
https://hdl.handle.net/2142/87246
Description
Title
Estrogen Receptor Ligands and Regulation of Gene Expression
Author(s)
Sheng, Shubin
Issue Date
2007
Doctoral Committee Chair(s)
Katzenellenbogen, Benita S.
Department of Study
Molecular and Integrative Physiology
Discipline
Molecular and Integrative Physiology
Degree Granting Institution
University of Illinois at Urbana-Champaign
Degree Name
Ph.D.
Degree Level
Dissertation
Keyword(s)
Biology, Cell
Language
eng
Abstract
Keratin13 (KRT13) and calcitonin receptor (CALCR) gene expression is differentially regulated by estradiol (E2) and the selective estrogen receptor modulators (SERMs) tamoxifen and raloxifene. KRT13 is a cytoskeleton protein while CALCR mediates the biological effects of calcitonin. These two genes may play important roles in breast cancer growth and metastasis. Analysis of the promoters and regulatory regions of these two genes was performed to explore the mechanism of estradiol and SERM regulation of these genes in breast cancer cells. Using a ChIP scanning approach, we identified a 2.5 kb regulatory region for KRT13 and two enhancer regions for CALCR. The regulatory activities of these regions were confirmed by reporter transactivation assays. The 2.5 kb regulatory region of KRT13 was further analyzed using progressive deletions and point mutations. The results demonstrated that three estrogen responsive elements (EREs) and three Sp1 sites were involved in the ligand dependent up-regulation of KRT13. The ERE at site1 is mainly involved in E2 activity, whereas the EREs at site2, site3 and the three Sp1 sites are involved in both E2 and tamoxifen activities. Next, ChIP assays were performed to examine the time courses of E2 and SERM-induced recruitment of ERalpha and cofactors on KRT13 and CALCR regulatory regions. I found that the differential recruitment of factors to the regulatory regions accompanied the time-dependent differential regulation of these genes. Taken together, my results suggest that: (1) the ligand-differential regulations of KRT13/CALCR are due to ligand-differential recruitment of ER and coactivators; (2) EREs mediate both E2 and tamoxifen effects, while certain EREs preferentially mediate the E2 effect, presumably dependent on the ERE sequence and promoter context. These findings provide new insight about gene regulation by different estrogen receptor ligands and mediation via estrogen receptors.
Use this login method if you
don't
have an
@illinois.edu
email address.
(Oops, I do have one)
IDEALS migrated to a new platform on June 23, 2022. If you created
your account prior to this date, you will have to reset your password
using the forgot-password link below.
